The 2025–2026 ISPE International Board of Directors has been announced. Newly elected Directors will assume their positions at the 2025 ISPE Annual Meeting & Expo.

NORTH BETHESDA, Md., Sept. 3, 2025 /PRNewswire/ -- The International Society for Pharmaceutical Engineering (ISPE) has announced the results of the 2025–2026 ISPE International Board of Directors election.

The ISPE International Board of Directors is responsible for the governance and strategic direction of ISPE. Board members will assume their elected positions at the 2025 ISPE Annual Meeting & Expo, taking place in Charlotte, North Carolina, USA, and virtually from 26 to 29 October.

The following pharmaceutical industry leaders have been elected to positions on the 2025–2026 ISPE International Board of Directors.

Executive Committee:

• Chair: Vivianne Arencibia, Vice President, Global Quality Systems and Compliance, Moderna
• Vice Chair: Ylva Ek, Founder, Robur Life Science Advisory AB
• Treasurer: David Churchward, Head of Operations Quality Compliance and External Affairs, AstraZeneca
• Secretary: Georg Singewald, PhD, Global Head of Quality and Compliance, Roche/Genentech
• Past Chair: Jeffrey Biskup, PE, Executive Chairman of the Board, CRB
• Ex Officio Non-Voting Member: Mike Martin, President and CEO, ISPE

Elected to a Second Term:

• Liz Dooley, Senior Director, Global Engineering and Technology, Johnson & Johnson 

New Directors:

• Jose Caraballo, Vice President Quality Systems, Compliance, and Quality Engineering, Kite, a Gilead Company
• Victor Cruz, Senior Vice President of Corporate Engineering and Global Health, Safety and Environmental, Eli Lilly & Company
• Francesco Intoccia, Senior Vice President Global Engineering Innovation, CSL Behring

The following Directors were elected in 2023 to serve a two-year term and will continue their service on the Board in 2025-2026:

• Norman Goldschmidt, President, Genesis AEC
• James Grunwald, Senior Vice President US Business Development, Arcadis
• Shanshan Liu, Technical Director, No Deviation Pte Ltd
• Vivien Santillan, Regional Director, Asia, Novatek International

Board Members Completing Service

• Scott Billman, Senior Vice President of Global Engineering, Technology, and Facilities, Solventum
• Sarah Pope Miksinski, PhD, Executive Director, CMC Regulatory Affairs, Gilead Sciences
• Timothy Watson, PhD, Vice President, Head of CMC Regulatory Affairs, Gilead Sciences

The election was run by an independent third party, which provided ISPE with the final audited results.

To learn more about ISPE, visit ISPE.org. To register for the upcoming 2025 ISPE Annual Meeting & Expo, visit ISPE.org/AM25.

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 23,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit ISPE.org.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ispe-announces-2025-2026-ispe-international-board-of-directors-election-results-302545525.html

SOURCE ISPE